Clinical features and outcomes of bacteraemia due to OXA-48-like carbapenemase-producing Klebsiella pneumoniae in a tertiary hospital
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Oct;36(8):498-501.
doi: 10.1016/j.eimc.2017.09.013.
Epub 2017 Nov 13.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Microbiología y Control de la Infección, Complejo Hospitalario Universitario de Canarias, La Laguna (Santa Cruz de Tenerife), España. Electronic address: ana_madueno@hotmail.com.
- 2 Servicio de Farmacia, Complejo Hospitalario Universitario de Canarias, La Laguna (Santa Cruz de Tenerife), España.
- 3 Sección de Enfermedades Infecciosas, Servicio de Medicina Interna, Complejo Hospitalario Universitario de Canarias, La Laguna (Santa Cruz de Tenerife), España.
- 4 Servicio de Microbiología y Control de la Infección, Complejo Hospitalario Universitario de Canarias, La Laguna (Santa Cruz de Tenerife), España.
- 5 Servicio de Microbiología y Control de la Infección, Complejo Hospitalario Universitario de Canarias, La Laguna (Santa Cruz de Tenerife), España; Departamento de Medicina Preventiva y Salud Pública, Universidad de La Laguna, La Laguna (Santa Cruz de Tenerife), España.
Abstract
Introduction:
Limited therapeutic options and high mortality make the management of OXA-48-like carbapenemase-producing Klebsiella pneumoniae (KPOXA-48) bacteraemia complicated. The aim of the study was to describe the clinical characteristics of KPOXA-48 bacteraemia between October 2013 and December 2016.
Material and methods:
The variables to analyse were retrospectively collected from medical records. Carbapenemase production was confirmed by phenotypic and molecular methods.
Results:
A total of 38 patients with bacteraemia were included, mainly classified as hospital-acquired (n=31). The majority of cases were secondary bacteraemia (n=26), most commonly arising from the urinary tract (n=11). All isolates presented a multidrug-resistant profile with the extended spectrum beta-lactamase CTX-M-15 and the carbapenemase OXA-48-like production. The crude mortality rate with adequate targeted antibiotic therapy was 0%, rising to 55% with inadequate treatment (p=0.0015).
Conclusions:
This study highlights the importance of identifying this resistance mechanism, the patient factors, type of bacteraemia and adequacy of antibiotic therapy in the outcome of bacteraemia.
Keywords:
Bacteraemia; Bacteriemia; Carbapenemasa; Carbapenemasa OXA-48; Carbapenemase; Klebsiella pneumoniae; OXA-48-like carbapenemase.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.
MeSH terms
-
Aged
-
Bacteremia* / diagnosis
-
Bacteremia* / drug therapy
-
Bacteremia* / epidemiology
-
Bacteremia* / microbiology
-
Bacterial Proteins / biosynthesis
-
Female
-
Humans
-
Klebsiella Infections* / diagnosis
-
Klebsiella Infections* / drug therapy
-
Klebsiella Infections* / epidemiology
-
Klebsiella Infections* / microbiology
-
Klebsiella pneumoniae* / enzymology
-
Male
-
Retrospective Studies
-
Tertiary Care Centers
-
beta-Lactamases / biosynthesis
Substances
-
Bacterial Proteins
-
beta-Lactamases
-
carbapenemase
-
oxacillinase